top of page
Rare autoimmune diseases cost Australian patients and the health system $1.2 billion a year, new report reveals.
Patients Australia today launched the Value of Medicines Report 2026 in Rare Autoimmune Diseases at Parliament House, revealing that two rare autoimmune conditions, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and generalised Myasthenia Gravis (gMG), together cost Australian patients, families and the health system an estimated $1.2 billion every year.
Patients Australia
Aug 193 min read
Pay up or go without: the medicines Australians struggle to access
The 2026 Patient Insights Report on Medicines Access paints a worrying picture about equity in Medicines Affordability.
Patients Australia
Jul 13 min read
bottom of page